Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Biotech’s trade secrets face growing threat from foreign influences, science leaders warn

    June 8, 2023

    Canadian biotech narrows trial population to lift solid tumor drug out of FDA hold

    June 7, 2023

    Biotechs face challenges as the industry’s annual bash returns to Boston

    June 5, 2023
    Facebook Twitter Instagram
    Your Biotech
    • Bio Technology

      Biotech’s trade secrets face growing threat from foreign influences, science leaders warn

      June 8, 2023

      Canadian biotech narrows trial population to lift solid tumor drug out of FDA hold

      June 7, 2023

      Biotechs face challenges as the industry’s annual bash returns to Boston

      June 5, 2023

      The Biotech Buying Bonanza: Why The FTC’s Amgen Battle Won’t Chill The Spree

      June 5, 2023

      China reaching for biotech breakthroughs in space

      June 2, 2023
    • Pharmaceutical

      Pharma company owner duped of ₹1.1 crore

      November 11, 2022

      Novavax cuts full-year revenue forecast again amid weak demand

      November 10, 2022

      Aurobindo units recall products in US market for manufacturing issues

      November 9, 2022

      AASLD 2022 | Ascentage Pharma Releases Phase I Results of IAP Antagonist APG-1387 in an Oral Report Showing Potential for Functionally Curing CHB

      November 8, 2022

      Trade Spotlight | What should you do with Amara Raja, Sun Pharma Advanced Research, Poly Medicure on Monday?

      November 7, 2022
    Your Biotech
    Home»Bio Technology»Needed for national security and competitiveness: a federal biodata infrastructure
    Bio Technology

    Needed for national security and competitiveness: a federal biodata infrastructure

    yourbiotechBy yourbiotechMarch 8, 2023Updated:March 8, 2023No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Connection lines Around Earth Globe, Blockchain network concept. Futuristic Technology Theme Background with Light Effect. 3D Rendering
    Share
    Facebook Twitter LinkedIn Pinterest Email

    An executive order from the Biden administration aims to build a robust economy “in a manner that benefits all Americans and the global community and maintains United States technological leadership and economic competitiveness.” The executive order acknowledged the importance of biodata to growing the U.S. bioeconomy and calls for “a biological data initiative.”

    That’s easier said than done. I see significant challenges that must be addressed ahead of May 10, the deadline by which several U.S. government agencies are required to report to the White House the biological data sources they deem critical to U.S. national interests. Agencies must also share by then their plans to fill data gaps, reduce security risks to biological data repositories, and outline each agency’s authorities, resources, and actions needed to support the data initiative.

    Efforts to explore and map the genomes and molecular processes that govern biological organisms are the modern data equivalent of the crude maps used by 15th-century seafarers exploring uncharted waters. Just as better maps increased economic and military power centuries ago, accurate information about how biological processes operate at the molecular, individual, population, and ecosystem scales will empower U.S. leadership in biomanufacturing and synthetic biology.

    Biodata matter to U.S. national and economic security

    The U.S. and Chinese governments both recognize that biotechnology is critical to national security and economic competitiveness. The U.S. bioeconomy already accounts for about 5% of the country’s gross domestic product ($960 billion) and is rapidly expanding. Biomanufacturing is becoming a major mode of production for a wide range of industries, from pharmaceuticals and industrial chemicals to food and fuels. Biotechnologies can also play important roles in ensuring supply chain resiliency, mitigating climate change, and restoring damaged ecosystems.

    National security concerns about biology have historically focused on bioweapons developed by individuals, terrorists, and state actors. Today, the biggest biotech threat may be the loss of U.S. economic competitiveness, stemming from a failure to transition the country’s enormous advantages in biological research into the infrastructure needed to grow the bioeconomy.

    The world is in the middle of a technology transformation. Biology — understanding how living things operate — is converging with the digital world. Biology is written in code, but instead of ones and zeroes it is written in As, Ts, Gs, and Cs, the nucleic acid sequences of DNA. Reading, writing, and editing this code will eventually have an even larger impact than the digital revolution.

    Biological data fuels growth of the bioeconomy

    Data is the essential fuel of the bioeconomy.

    The quantity and variety of biodata are driven by new methods for observing and measuring biological processes, and new biotechnology applications, including synthetic biology and biomanufacturing. Genomics, which involves deciphering the sequence of base pairs in the DNA of an individual, generates especially large amounts of data. A single human genome consists of more than 3 billion base pairs, the equivalent of 200 gigabytes of data.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleUzbekistan cough syrup deaths | Process underway to cancel the license of Marion Biotech says, official
    Next Article Johnson & Johnson layoffs hit medtech business, with more than 350 cuts in California
    yourbiotech
    • Website

    Related Posts

    Biotech’s trade secrets face growing threat from foreign influences, science leaders warn

    June 8, 2023

    Canadian biotech narrows trial population to lift solid tumor drug out of FDA hold

    June 7, 2023

    Biotechs face challenges as the industry’s annual bash returns to Boston

    June 5, 2023

    The Biotech Buying Bonanza: Why The FTC’s Amgen Battle Won’t Chill The Spree

    June 5, 2023

    Leave A Reply Cancel Reply

    Our Picks

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us
    About Us

    We provide a wide range of customized, integrated B2B and B2C digital marketing services solutions that are ideal for your business.

    We're accepting new partnerships right now.

    Email Us: info@yourmartech.com
    Contact: +1-530-518-1420

    Our Brands
    • Your Martech
    • Your HR Tech
    • Your Fin Tech
    • Your Revenue
    • Your Info Tech
    • Your POS Tech
    • Your Health Tech
    SUBSCRIBE NOW
    Loading
    LinkedIn
    • Privacy Policy
    © 2022 Vigarbiz Inc. Designed by Vigarbiz Media

    Type above and press Enter to search. Press Esc to cancel.